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Abstract
Objectives: The aims of this study were to model jointly the incidence rates of six smoking related
cancers in the Yorkshire region of England, to explore the patterns of spatial correlation amongst
them, and to estimate the relative weight of smoking and other shared risk factors for the relevant
disease sites, both before and after adjustment for socioeconomic background (SEB).
Methods: Data on the incidence of oesophagus, stomach, pancreas, lung, kidney, and bladder
cancers between 1983 and 2003 were extracted from the Northern & Yorkshire Cancer Registry
database for the 532 electoral wards in the Yorkshire region. Using postcode of residence, each
case was assigned an area-based measure of SEB using the Townsend index. Standardised incidence
ratios (SIRs) were calculated for each cancer site and their correlations investigated. The joint
analysis of the spatial variation in incidence used a Bayesian shared-component model. Three
components were included to represent differences in smoking (for all six sites), bodyweight/
obesity (for oesophagus, pancreas and kidney cancers) and diet/alcohol consumption (for
oesophagus and stomach cancers).
Results: The incidence of cancers of the oesophagus, pancreas, kidney, and bladder was relatively
evenly distributed across the region. The incidence of stomach and lung cancers was more
clustered around the urban areas in the south of the region, and these two cancers were
significantly associated with higher levels of area deprivation. The incidence of lung cancer was most
impacted by adjustment for SEB, with the rural/urban split becoming less apparent. The component
representing smoking had a larger effect on cancer incidence in the eastern part of the region. The
effects of the other two components were small and disappeared after adjustment for SEB.
Conclusion: This study demonstrates the feasibility of joint disease modelling using data from six
cancer sites. Incidence estimates are more precise than those obtained without smoothing. This
methodology may be an important tool to help authorities evaluate healthcare system performance
and the impact of policies.
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Background
Mapping of the geographical distribution of cancer inci-
dence, survival, or mortality rates can help us understand
spatial patterns of disease and identify differences in dis-
ease burden across an area. These maps can be used by
those involved in the planning of services or in cancer pre-
vention and control programmes, both locally and
nationally, and can provide useful background informa-
tion for academics, the government, and the general pub-
lic. For example, the Cancer E-Atlas provides basic
statistics (available as maps) on the incidence of and mor-
tality from the most common cancers across England [1].
Such maps tend to show relative risk (RR), expressed as
population-based standardised incidence or mortality
ratios (SIRs/SMRs) and can be calculated at varying levels
of geographical resolution. There is a need to maintain a
balance between preserving patient privacy and obtaining
fine geographical resolution, and in the UK this is com-
monly overcome by using the unit of electoral wards,
which include an average of 5,000 residents. However,
population-based rates across such relatively small geo-
graphical areas can vary greatly due to the differences in
population sizes and incidence rates. Furthermore,
derived SIRs/SMRs can be unstable for areas with small
populations[2]. One way to address this problem is to use
spatial smoothing techniques that recognise that observa-
tions from the same area share similar properties. In this
way the variability or 'noise' can be reduced. Many differ-
ent approaches to spatial smoothing have been devel-
oped, but the one that has gained wide acceptance and
applicability is that of Besag, York and Mollie (the BYM
model), which allows for both heterogeneous and spa-
tially structured random effects[3].
Much of the work in the area of spatial smoothing has
focused on the modelling of a single disease. However,
many diseases share common risk factors and more
recently joint disease mapping has emerged. By 'borrow-
ing' information from different diseases, the estimates
(rates) can be further improved [4]. Several methods for
joint disease mapping have been proposed, using both
Bayesian and non-Bayesian techniques [5-9]. Manda &
Leyland compared maximum likelihood (frequentist)
and Bayesian estimation methods using Markov Chain
Monte Carlo (MCMC) for multivariate spatial disease
models[10]. They found that whilst the parameters are
estimated similarly under the two methods, random
effects variance estimates are generally attenuated under
the frequentist approach compared to the Bayesian
approach. They suggest that MCMC is easier to implement
and provides more reliable estimates for many realistic
epidemiological problems. Assunção and Castro showed
that disease incidence rates obtained using a multivariate
Bayesian model were more precise, i.e. with smaller con-
fidence intervals (CIs), compared to those obtained with
classical indirect standardisation, which had very large CIs
due to the small number of cases. However, this analysis
did not consider spatial effects[4].
A further extension is the inclusion of shared compo-
nents[8], which are common factors shared by different
subsets of diseases. The area-specific values of these
shared components and the relative contribution
(weight) of the component to each relevant disease may
be estimated[11]. One of the most common shared risk
factors for cancer is cigarette smoking[12]. In this study we
chose to model the incidence rates of six cancers for which
smoking is a major risk factor; cancers of the oesophagus,
stomach, pancreas, lung, kidney, and bladder. These are
amongst the 15 most common cancers in the Yorkshire
region of England and together account for approximately
30% of all cancer cases[13]. In addition to smoking, these
cancers share other risk factors; oesophagus, pancreas, and
kidney cancers are linked to bodyweight/obesity;
oesophagus and stomach cancer are associated with diet
(including alcohol consumption)[12]. The aims of this
study were to model jointly the incidence rates of these six
cancers in the Yorkshire region, to explore the patterns of
spatial correlation amongst them, and to estimate the rel-
ative weight of the shared risk factors for each site, both
before and after adjustment for socioeconomic back-
ground (SEB).
Methods
The six cancer sites included in this study were oesopha-
gus (ICD10 code C15), stomach (C16), pancreas (C25),
lung (C33-34), kidney (C64), and bladder (C67). Data on
cancer incidence between 1983 and 2003 were extracted
from the Northern & Yorkshire Cancer Registry & Infor-
mation Service database for the 532 electoral wards in the
Yorkshire Health Region according to the 1991 census.
Using the postcode of residence at the time of diagnosis,
each person was assigned an area-based measure of SEB
using the Townsend index [14]. SIRs were calculated for
each cancer site (with the number of expected cases calcu-
lated using the average number of cases per ward observed
in Yorkshire and the population in 1991) and correlations
amongst these were investigated.
The methodology used was an alternative to that
described in Langford et al[5], Leyland et al [6], Assunção
and Castro [4], and Feltbower et al[15], whereby joint
modelling of multiple diseases is achieved using a multi-
variate normal structure on relative risks, the first two
using non-Bayesian methods and the later two using
Bayesian formulations. In this study, the joint analysis of
the spatial variation of incidence rates of the six cancers
was modelled by the shared-component model, in which
different cancers share latent spatial components. We for-
mulated the joint modelling from a Bayesian perspective,International Journal of Health Geographics 2008, 7:41 http://www.ij-healthgeographics.com/content/7/1/41
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similar to that described in Held et al[16], which is an
extension of the formulations described initially in Knorr-
Held and Best[8] for the two-disease setting. The common
feature of this class of shared-common models is that the
latent components act as surrogates for geographical vari-
ations of the unobserved spatially-structured risk factors
that affect some or all diseases.
Suppose that the region under consideration has been
divided into I contiguous sub-regions; these are areas or
electoral wards for the Yorkshire region in our case. Let Oij
represent the observed number of incident cases of cancer
j in area i (1 ≤ i ≤ I = 532, 1 ≤ j ≤ 6, in our case). It is
assumed that the observed counts follow Poisson distri-
butions with mean μij = EijRij, where Eij and Rij are the
known expected number of cases and unknown relative
risk, respectively, in area i for disease j. The maximum
likelihood estimate of the relative risk of disease j in area
i is the usual standardised morbidity/incidence ratio   =
Oij/Eij. It is well known that these crude risk ratios are mis-
leading, particularly when the diseases are rare or the areas
are small. Thus, more reliable estimates of relative risks for
rare diseases or small areas can be obtained by borrowing
information from neighbouring areas.
The basic BYM (Besag, York and Mollie) model [3]
decomposes the log of disease-specific area-level relative
risks into the sum of two random effects: one which is
unstructured (heterogeneous) and the other spatially
structured (dependent). The unstructured random effects
are assumed to follow a normal distribution. The spatially
structured effects are modelled by the intrinsic condi-
tional autoregressive normal (CAR Normal) prior, which,
in simple formulation, specifies that the conditional dis-
tribution of each area-specific spatially structured effect,
given all other spatial effects, is a normal distribution with
mean equal to the average of its bordering neighbours,
and variance inversely proportional to the number of
these neighbours; the more neighbours an area has, the
greater the precision is for that area effect.
Rather than using a multivariate normal prior to assess
spatial correlations amongst the six cancers, we used a
shared-component model [8,16]. In our model, we
included three shared components (chosen a priori based
on common risk factors[12]): the first relevant to all six
cancer sites, which we interpret to act as a surrogate for
variations in smoking; the second representing differences
in bodyweight/obesity for oesophagus, pancreas, and kid-
ney; the third for oesophagus and stomach cancer repre-
senting variations in diet/alcohol consumption. We also
included the relative weights of each common component
for the relevant cancers. The resulting model enables us to
determine the extent of the variation exhibited through
common geographical patterns in diseases in space. Thus,
following Held et al, we modelled the log relative risk as:
where Ri1 is the log relative risk for oesophagus cancer in
ward i, Ri2 is the log relative risk for stomach cancer, and
likewise Ri3, Ri4, Ri5 and Ri6 for pancreas, lung, kidney, and
bladder cancers, respectively. The parameter αj is the dis-
ease-specific intercept and βj are the disease-specific risk
coefficients associated with the risk vector x;  φ1i is the
shared smoking component common to all six cancers; φ2i
is the shared bodyweight/obesity  component relevant to
oesophagus, pancreas, and kidney cancers only; and φ3i is
the shared diet/alcohol  component for oesophagus and
stomach cancers only. The unknown parameters κ allow
for different risk gradients for the relevant diseases and εij
are the disease-specific heterogeneous effects, capturing
possible extra-Poisson variation that is not explained by
the included terms.
For a Bayesian model to be completed, all unknown
parameters, whether for fixed or random effects, are given
prior distributions. Where prior knowledge is available,
this should be reflected in the prior distributions, other-
wise prior ignorance is assumed on the distributions of
parameters. We want priors that combine the BYM frame-
work to link risk in space. For the purpose of this applica-
tion, the shared spatial random effects φi were given a
prior distribution to capture local dependence in space.
The disease-specific heterogeneity terms were modelled to
arise from a multivariate normal prior distribution with
covariance matrix Σ to allow for correlations amongst the
cancers. Since we used the CAR Normal prior, with sum-
to-zero constraints on the random effect terms, we
assigned a flat prior on the overall disease risk terms, αj,
and the fixed effects were assigned independent Nor-
mal(0,103) prior distributions. The logarithms of the scal-
ing parameters were assigned independent Normal(0,5)
prior distributions, and the shared component precision
parameters τ1, τ2, and τ3 were independently assigned a
conjugate hyper-prior Gamma (0.5, 0.0005) distribu-
tion[17], which is weakly informative. This implies that, a
priori, the variances 1/τ1, 1/τ2 and 1/τ3 of the respective
shared latent components φ1, φ2 and φ3 follow an inverse
gamma distribution with a 99% probability that the vari-
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ance lies between 0.000151 and 6.25, with a mode at
0.00033, thus concentrated towards 0, which is conserva-
tive. This is a reasonable assumption as the differences in
risk are likely to be minimal due to relative equity across
the region in any information or prevention campaigns in
operation and the availability of treatments. In addition,
we adjusted for the effects of SEB. The precision matrix Σ-
1 for the multivariate normal unstructured random effects
was assigned a Wishart(Q,6) prior distribution, where Q
is set to be a diagonal matrix with 1s. The choice of these
hyper-prior distributions of the precision terms may result
in some sensitivity of the model results, in particular the
overall smoothed relative risks of the cancers.
The model was fitted to the data using full Bayesian esti-
mation within the WinBUGS software [18]. The Win-
BUGS code used for the shared component model is
available as additional file 1 on the IJHG website. For each
model, three independent chains were run for 50,000 iter-
ations. We monitored all fixed effects, weight and variance
parameters for convergence. We used the Brooks-Gelman-
Rubin diagnostic tool [19], which confirmed rapid con-
vergence by 20,000 iterations. Thus, we used the remain-
ing 30,000 iterations from each of the three chains for
posterior summaries.
We compared the variations of the joint model using the
Deviance Information Criterion (DIC)[20]. The DIC is
defined as DIC = +pD where   is the posterior mean of
the deviance and measures model fit; and pD is the effec-
tive number of model parameters and measures model
complexity. The DIC works on similar principles as the
non-Bayesian Akaike Information Criterion (AIC). The
DIC value of the joint modelling of the six cancers using
three shared components was compared to the sum of the
DIC values from the six individual BYM models. Sum-
ming individual DIC values assumes that the six cancers
are independent[16]. The joint model had a DIC value of
18980.5 and the sum of the DIC values from the individ-
ual BYM models was 19083.04. This shows a great
improvement in the DIC vales for the joint model. The
results presented here are from the joint model.
Results
The total population of the Yorkshire region in 1991 was
3,676,305 persons. The minimum number of people liv-
ing in a ward was 489 and the maximum was 26,705. Fig-
ure 1 shows the deprivation score for each ward. The more
rural wards in the north of the region were generally more
affluent (lighter orange/yellow), whilst the urban areas of
Leeds, Bradford, and Hull were more deprived (darker
orange/brown). Across the region during the study period
there were 7,444 oesophagus cancers, 15,045 stomach
cancers, 8,522 pancreas cancers, 54,520 lung cancers,
5,918 kidney cancers, and 15,072 bladder cancers. The
mean and range of the ward SIRs for each of the six can-
cers are shown in Table 1, and the correlations amongst
the ward SIRs are shown in Table 2. Cancers of the
oesophagus and pancreas were more common than
expected in the region, whilst stomach and lung cancer
were less common than expected. The correlation
amongst the ward SIRs was highest for stomach and lung
cancer (0.49), followed by lung and pancreas and lung
and bladder (both 0.34). The correlation was lowest
between kidney and lung cancer (0.11).
Figure 2 shows the raw (unsmoothed) SIRs for each can-
cer. The incidence of cancers of the oesophagus, pancreas,
kidney, and bladder appear to be relatively evenly distrib-
uted across the region. In contrast, the incidence of stom-
ach and lung cancers were more clustered around the
urban areas in the south of the region. As expected,
smoothing generally decreased the number of wards with
the highest (>= 1.15) and lowest (< 0.85) incidence rates
and increased the number of wards in the intermediate
categories (results not shown but available on request).
The exception to this was an increase in the highest inci-
D D
Table 1: Mean and range of the standardised incidence ratios for 
each cancer
Mean SIR Minimum SIR Maximum SIR
Oesophagus 1.06 0.00 3.24
Stomach 0.94 0.00 2.55
Pancreas 1.02 0.00 2.76
Lung 0.92 0.07 2.80
Kidney 1.00 0.00 2.79
Bladder 1.01 0.00 2.58
Table 2: Correlations between the standardised incidence ratios for each cancer
Oesophagus Stomach Pancreas Lung Kidney Bladder
Oesophagus 1.00 - - - - -
Stomach 0.23 1.00 - - - -
Pancreas 0.26 0.23 1.00 - - -
Lung 0.31 0.49 0.25 1.00 - -
Kidney 0.16 0.15 0.20 0.11 1.00 -
Bladder 0.25 0.27 0.34 0.34 0.23 1.00International Journal of Health Geographics 2008, 7:41 http://www.ij-healthgeographics.com/content/7/1/41
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dence category for lung and stomach cancers. The general
patterns seen in the unsmoothed maps remained
unchanged. Figure 3 shows the smoothed results after
adjustment for SEB. The incidence of lung cancer was
most impacted by adjustment for SEB, becoming more
evenly distributed across the region, and the concentra-
tion of high incidence wards in the urban area of Leeds/
Bradford became less apparent. Adjustment for SEB
resulted in a similar change for stomach cancer, though to
a lesser extent. Adjustment made little difference to the
spatial distribution of oesophagus, pancreas, kidney, and
bladder cancers.
The estimates of the effects of the three shared compo-
nents were also mapped. Before adjustment for SEB, com-
ponent 1 (which was acting as a surrogate for smoking)
had a larger effect on cancer incidence in the urban areas
around Leeds and in the eastern part of the region (Figure
4). After adjustment, the effect disappeared from around
Leeds but became more pronounced in the eastern part of
the region. Component 2 (a surrogate for bodyweight/
obesity) had a larger effect in the northern part of the
region and a smaller effect around Leeds and Bradford in
the unadjusted analysis (Figure 5). After adjustment for
SEB, these differences disappeared. In the unadjusted
analysis, the effect of component 3 (a surrogate for diet/
alcohol consumption) showed little variation with an
increased effect in Humberside (Figure 6). Adjustment for
SEB had no effect on the cancer rates.
Table 3 shows the relative weight, or level of importance,
that each shared component has for the different cancers,
without adjustment for SEB. Component 1, representing
smoking, was more important for lung cancer than for the
other five cancers and this was significant relative to all
cancers except stomach. In addition, this component was
more important for stomach cancer than for the other
cancers (except lung cancer) and this was significant rela-
tive to oesophagus, pancreas, and kidney cancers. Compo-
nent 1 was less important for kidney cancer than the other
five cancers. This component carried equal weight
between stomach and lung cancers, with a ratio of 0.90
(95% CI 0.67–1.17). Shared component 2, representing
bodyweight/obesity, was more important for oesophagus
cancer relative to pancreas and kidney cancers. This com-
ponent carried equal weight for pancreas and kidney can-
Map of the 1991 Townsend index of deprivation for each ward in Yorkshire Figure 1
Map of the 1991 Townsend index of deprivation for each ward in Yorkshire.
02 5 5 0 12.5 Kilometers
Hull Bradford
Leeds
(194) < -2.5
(120) -2.5 - -0.9
(89) -0.9 - 1.4
(68) 1.4 - 3.5
(61) >= 3.5International Journal of Health Geographics 2008, 7:41 http://www.ij-healthgeographics.com/content/7/1/41
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cer, with a ratio of 1.05 (95% CI 0.49–2.32). Shared
component 3, representing diet/alcohol consumption,
was more important for oesophagus cancer relative to
stomach cancer, though not significantly so, with a ratio
of 2.05 (95% CI 0.56–6.15). Table 4 shows the ratios after
adjustment for SEB. In shared component 1, the weight of
lung cancer was smaller and the weight of bladder cancer
was larger, but none of the results was statistically signifi-
cant. The results for shared components 2 and 3 showed
the same patterns as in the unadjusted analysis.
Table 5 shows the relative risk of cancer incidence by SEB
fifths. Living in a more deprived area was associated with
an increased incidence of lung and stomach cancers (RR =
Maps of the raw (unsmoothed) standardised incidence ratios for six cancers in Yorkshire between 1983 and 2003 Figure 2
Maps of the raw (unsmoothed) standardised incidence ratios for six cancers in Yorkshire between 1983 and 
2003.
Oesophagus 
02 5 5 0 12.5 Kilometers
(175)  < 0.85
(51)  0.85 - 0.95
(60)  0.95 - 1.05
(49)  1.05 - 1.15
(197)  >= 1.15
Pancreas 
02 5 5 0 12.5 Kilometers
(173)  < 0.85
(70)  0.85 - 0.95
(64)  0.95 - 1.05
(52)  1.5 - 1.15
(173)  >= 1.15
Kidney 
02 5 5 0 12.5 Kilometers
(201)  < 0.85
(61)  0.85 - 0.95
(58)  0.95 - 1.05
(36)  1.05 - 1.15
(176)  >= 1.15
Stomach 
02 5 5 0 12.5 Kilometers
(218)  < 0.85
(69)  0.85 - 0.95
(62)  0.95 - 1.05
(67)  1.05 - 1.15
(116) >= 1.15
Lung 
02 5 5 0 12.5 Kilometers
(229)  < 0.85
(94) 0.85 - 0.95
(61)  0.95 - 1.05
(40)  1.05 - 1.15
(108)  >= 1.15
Bladder 
02 5 5 0 12.5 Kilometers
(177)  < 0.85
(58)  0.85 - 0.95
(75)  0.95 - 1.05
(59)  1.05 - 1.15
(163)  >= 1.15International Journal of Health Geographics 2008, 7:41 http://www.ij-healthgeographics.com/content/7/1/41
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1.63, 95% CI 1.47–1.78, and RR = 1.33, 95% CI 1.19–
1.48, respectively in the most deprived fifth). There also
appeared to be a positive association between living in a
more deprived area and an increased incidence of
oesophagus and pancreas, whilst the opposite was seen
for kidney and bladder cancers, although none of these
was statistically significant.
We performed a sensitivity analysis to evaluate variation
of the results in response to the choice of the gamma
hyper-prior distribution of the precision parameters τ1, τ2,
and τ3, we assigned an alternative conjugate hyper-prior
Gamma (1,1). Using this specification, the variances 1/τ1,
1/τ2 and 1/τ3 of the respective shared latent components
φ1, φ2, and φ3 have a 99% probability of lying between
Maps of the posterior median smoothed standardised incidence ratios for six cancers in Yorkshire between 1983 and 2003,  adjusted for socioeconomic background Figure 3
Maps of the posterior median smoothed standardised incidence ratios for six cancers in Yorkshire between 
1983 and 2003, adjusted for socioeconomic background.
Oesophagus 
02 5 5 0 12.5 Kilometers
(109)  < 0.85
(106)  0.85 - 0.95
(92)  0.95 - 1.05
(82)  1.05 - 1.15
(143)  >= 1.15
Pancreas 
02 5 5 0 12.5 Kilometers
(100)  < 0.85
(104)  0.85 - 0.95
(119)  0.95 - 1.05
(89)  1.05 - 1.15
(120)  >= 1.15
Kidney 
02 5 5 0 12.5 Kilometers
(89)  < 0.85
(102)  0.85 - 0.95
(130)  0.95 - 1.05
(106)  1.05 - 1.15
(105)  >= 1.15
Stomach 
02 5 5 0 12.5 Kilometers
(104)  < 0.85
(110)  0.85 - 0.95
(108)  0.95 - 1.05
(87)  1.05 - 1.15
(123)  >= 1.15
Lung 
02 5 5 0 12.5 Kilometers
(94)  < 0.85
(106)  0.85 - 0.95
(122)  0.95 - 1.05
(91)  1.05 - 1.15
(119)  >= 1.15
Bladder 
02 5 5 0 12.5 Kilometers
(107)  < 0.85
(104)  0.85 - 0.95
(102)  0.95 - 1.05
(89)  1.05 - 1.15
(130)  >= 1.15International Journal of Health Geographics 2008, 7:41 http://www.ij-healthgeographics.com/content/7/1/41
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Maps of the posterior medians of shared component 1 (representing smoking, including all six cancers), unadjusted and  adjusted for socioeconomic background Figure 4
Maps of the posterior medians of shared component 1 (representing smoking, including all six cancers), unad-
justed and adjusted for socioeconomic background.
Unadjusted 
02 5 5 0 12.5 Kilometers
(5)  < 0.85
(144)  0.85 - 0.95
(244)  0.95 - 1.05
(115)  1.05 - 1.15
(24)  >= 1.15
Adjusted 
02 5 5 0 12.5 Kilometers
(3)  < 0.85
(86)  0.85 - 0.95
(366)  0.95 - 1.05
(59)  1.05 - 1.15
(18)  >= 1.15International Journal of Health Geographics 2008, 7:41 http://www.ij-healthgeographics.com/content/7/1/41
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Maps of the posterior medians of shared component 2 (representing obesity/bodyweight, including oesophagus, pancreas and  kidney cancers), unadjusted and adjusted for socioeconomic background Figure 5
Maps of the posterior medians of shared component 2 (representing obesity/bodyweight, including oesopha-
gus, pancreas and kidney cancers), unadjusted and adjusted for socioeconomic background.
Unadjusted 
02 5 5 0 12.5 Kilometers
(0)  < 0.85
(121)  0.85 - 0.95
(277)  0.95 - 1.05
(134)  1.05 - 1.15
(0)  >= 1.15
Adjusted 
02 5 5 0 12.5 Kilometers
(0)  < 0.85
(1)  0.85 - 0.95
(531)  0.95 - 1.05
(0)  1.05 - 1.15
(0)  >= 1.15International Journal of Health Geographics 2008, 7:41 http://www.ij-healthgeographics.com/content/7/1/41
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Maps of the posterior medians of shared component 3 (representing diet/alcohol consumption, including oesophagus and  stomach cancers), unadjusted and adjusted for socioeconomic background Figure 6
Maps of the posterior medians of shared component 3 (representing diet/alcohol consumption, including 
oesophagus and stomach cancers), unadjusted and adjusted for socioeconomic background.
Unadjusted 
02 5 5 0 12.5 Kilometers
(0)  < 0.85
(0)  0.85 - 0.95
(453)  0.95 - 1.05
(79)  1.05 - 1.15
(0)  >= 1.15
Adjusted 
02 5 5 0 12.5 Kilometers
(0)  < 0.85
(0)  0.85 - 0.95
(453)  0.95 - 1.05
(79)  1.05 - 1.15
(0)  >= 1.15International Journal of Health Geographics 2008, 7:41 http://www.ij-healthgeographics.com/content/7/1/41
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0.217 and 100, and a mode at 0.5, thus away from 0. We
choose to investigate the overall unadjusted smoothed
relative risks for lung and stomach cancers, which were
most common in the region. Figure 7 shows a comparison
of the median smoothed RRs of stomach (A) and lung (B)
cancer for the two different specifications of hyper-prior
Table 3: Posterior median (95% CI) relative weights of each cancer in the shared components analysis (unadjusted for socioeconomic 
background)
Oesophagus Stomach Pancreas Lung Kidney Bladder
Oesophagus 1 1.00
2 1.00
3 1.00
Stomach 1 0.53 (0.26–0.92) 1.00
2 - 1.00
3 2.05 (0.56–6.15) -
Pancreas 1 0.89 (0.46–1.62) 1.67 (1.04–3.02) 1.00
2 1.72 (0.67–3.59) - 1.00
3 -- 1 . 0 0
Lung 1 0.48 (0.24–0.80) 0.90 (0.67–1.17) 0.54 (0.30–0.84) 1.00
2 ----
3 ----
Kidney 1 1.10 (0.52–2.22) 2.06 (1.19–3.95) 1.23 (0.65–2.42) 2.30 (1.34–4.47) 1.00
2 1.81 (0.66–4.09) - 1.05 (0.49–2.32) - 1.00
3 -----
Bladder 1 0.81 (0.41–1.45) 1.51 (0.96–2.73) 0.91 (0.52–1.58) 1.69 (1.07–3.05) 0.73 (0.38–1.40) 1.00
2 ----- -
3 ----- -
1 – The shared component representing smoking; 2 – The shared component representing bodyweight/obesity; 3 – The shared component 
representing diet/alcohol consumption.
The figures in the main body of the table represent the weight of the cancer listed along the top row relative to the cancers listed along the left 
hand side (with 95% confidence intervals). If the RR is > 1.00 the cancer along the top row has more weight, if the RR is < 1.00 the cancer along the 
left hand side has more weight.
Table 4: Posterior median (95% CI) relative weights of each cancer in the shared components analysis (adjusted for socioeconomic 
background)
Oesophagus Stomach Pancreas Lung Kidney Bladder
Oesophagus 1 1.00
2 1.00
3 1.00
Stomach 1 1.06 (0.45–2.20) 1.00
2 - 1.00
3 2.29 (0.58–6.47) 1.00
Pancreas 1 0.94 (0.47–1.69) 0.89 (0.49–1.68) 1.00
2 1.89 (0.58–5.16) - 1.00
3 -- 1 . 0 0
Lung 1 1.09 (0.53–1.95) 1.04 (0.61–1.64) 1.16 (0.65–1.92) 1.00
2 ----
3 ----
Kidney 1 1.13 (0.52–2.32) 1.07 (0.57–2.08) 1.20 (0.67–2.28) 1.04 (0.60–1.99) 1.00
2 2.12 (0.54–5.88) - 1.10 (0.44–2.61) - 1.00
3 -----
Bladder 1 0.75 (0.37–1.29) 0.72 (0.40–1.19) 0.81 (0.47–1.24) 0.69 (0.45–1.02) 0.67 (0.35–1.10) 1.00
2 ----- -
3 ----- -
1 – The shared component representing smoking; 2 – The shared component representing bodyweight/obesity; 3 – The shared component 
representing diet/alcohol consumption.
The figures in the main body of the table represent the weight of the cancer listed along the top row relative to the cancers listed along the left 
hand side (with 95% confidence intervals). If the RR is > 1.00 the cancer along the top row has more weight, if the RR is < 1.00 the cancer along the 
left hand side has more weight.International Journal of Health Geographics 2008, 7:41 http://www.ij-healthgeographics.com/content/7/1/41
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distributions. In both cases, the points lie perfectly on the
line of unity, showing agreement of the smoothed risks
and confirming previous work showing that the choice of
hyper-prior has no effect on the smoothed SIRs[2].
Discussion
This study demonstrates the feasibility of joint disease
modelling using data from six cancer sites. The resulting
maps clearly show the geographical differences in the inci-
dence of the six cancers. Smoothing allows us to see the
inherent spatial patterns of cancer incidence as the varia-
bility or 'noise' has been removed. The estimates are more
precise and the associated CIs are smaller than those
obtained without smoothing. Generally, the effect of
smoothing was to reduce the number of wards in the
highest and lowest incidence categories, thereby increas-
ing the number in the intermediate categories. It is well
known that after smoothing the RR estimates from areas
with small populations are pulled towards the average of
1, while those from areas with larger populations are
unchanged from the raw risk[2].
Increasing area deprivation was significantly associated
with higher incidence of lung and stomach cancers and
there was a clear dose response relationship. Before
adjusting for SEB, the incidence of lung and stomach can-
cers was higher around the urban areas of Leeds and Brad-
ford. Adjusting for SEB weakened this effect, but there was
still a cluster of high incidence wards in these areas. The
results of the shared components analysis show that the
'smoking' component had more effect in the areas around
Leeds, and that the effect was greatest for lung and stom-
ach cancers, but this diminished after adjustment for SEB.
Component 2 (representing bodyweight/obesity) was
more important in the northern part of the region before
adjusting for SEB, but this effect disappeared after adjust-
ment. This component and component 3 (representing
diet/alcohol consumption) were relatively more impor-
tant for oesophagus cancer than the other cancers, but
these results were not statistically significant. It may be
that the effects of these risk factors are too small to be
detected using this methodology. Although the random
effects shared components are loosely interpreted to
reflect these variables, data on smoking prevalence, levels
of obesity and dietary intake are not actually available at
such a fine geographical level. Ideally, we would want to
include these measures as covariates in the model. In
addition, there are other risk factors which could be
explored, but their effects are likely to be smaller and not
detectable with this type of analysis.
Most cancers have a long latency period, with many years
between any exposure to risk factors (e.g. smoking at age
30) and diagnosis of disease (e.g. lung cancer at age 60).
Therefore, figures 4, 5, 6 may represent maps of historic
smoking prevalence, bodyweight patterns and dietary
habits. A possible extension to this work would be to
include a temporal component in the model, which may
improve the correlations further and could reflect the
latency between an exposure and disease, or the effect of a
new screening programme or new treatment[21].
In our application we have shown that a joint model of
the six cancer sites offers a great improvement over indi-
vidual BYM models (as demonstrated by the DIC criteria).
However, the interpretation of the derived smoothed
maps should be treated with caution because, although
they are a great improvement over unsmoothed maps,
there remain confounding factors, differences in popula-
tion size, and area factors. In addition, the results may suf-
fer from over- or under-estimation, due to the edge effects
phenomenon. We used an adjacency matrix to ascertain
the number of neighbours each ward had. However, some
wards in the Yorkshire region border wards in other
regions. Data were not available for other regions; thus,
these wards have missing neighbours, which may intro-
duce some bias when averaging rates or when estimating
spatial effects as their variances are inversely related to the
total number of areas. Nonetheless, Bayesian hierarchical
modelling of relative risks has many advantages over
other methods when smoothing across small geographic
areas.
This analysis was carried out using data between 1983 and
2003, a period when electoral wards were the most com-
monly used small geographical unit and populations were
available at that level. Super Output Areas (SOAs), intro-
duced in the 2001 census, are now replacing wards and in
Table 5: Posterior median (95% CI) relative risk of cancer incidence by Townsend quintile
Oesophagus Stomach Pancreas Lung Kidney Bladder
I (most affluent) 1.00 1.00 1.00 1.00 1.00 1.00
II 1.11 (0.99–1.24) 1.11 (1.01–1.22) 1.12 (1.01–1.24) 1.12 (1.04–1.20) 1.09 (0.98–1.22) 1.03 (0.94–1.12)
III 1.16 (1.03–1.31) 1.24 (1.13–1.37) 1.09 (0.98–1.22) 1.31 (1.21–1.41) 0.96 (0.86–1.09) 1.06 (0.96–1.17)
IV 1.16 (1.02–1.32) 1.27 (1.15–1.41) 1.10 (0.98–1.24) 1.47 (1.35–1.59) 0.97 (0.86–1.10) 0.99 (0.89–1.10)
V (most deprived) 1.07 (0.93–1.23) 1.33 (1.19–1.48) 1.03 (0.91–1.16) 1.63 (1.47–1.78) 0.89 (0.78–1.01) 0.94 (0.84–1.05)International Journal of Health Geographics 2008, 7:41 http://www.ij-healthgeographics.com/content/7/1/41
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the near future wards will be obsolete. However, there is
no reason why similar studies could not be carried out at
the SOA (or other small area) level.
This type of analysis may be useful for authorities to eval-
uate healthcare system performance and adjust their poli-
cies as a result. Such data may also help construct or
confirm research hypotheses. In both situations, the aim
is to obtain parameter estimates that are as accurate as
possible[21]. In this case, we attempted to assess the effect
of smoking, bodyweight/obesity, and diet/alcohol on six
cancers. It is estimated that over half of all cases of cancer
could be prevented through changes to lifestyle, such as
quitting smoking, maintaining a healthy weight, and
avoiding excessive alcohol consumption. This is therefore
an important area of focus and this methodology may
prove valuable.
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